Kroon BB - Search Results

1

Value of laboratory tests in monitoring acute regional toxicity after isolated limb perfusion.

Vrouenraets BC, Kroon BB, Klaase JM, Bonfrer JM, Nieweg OE, van Slooten GW, van Dongen JA. Vrouenraets BC, et al. Among authors: kroon bb. Ann Surg Oncol. 1997 Jan;4(1):88-94. doi: 10.1007/BF02316815. Ann Surg Oncol. 1997. PMID: 8985522

2

Isolated limb perfusion for melanoma.

Kroon BB, Noorda EM, Vrouenraets BC, Nieweg OE. Kroon BB, et al. J Surg Oncol. 2002 Apr;79(4):252-5. doi: 10.1002/jso.10077. J Surg Oncol. 2002. PMID: 11920783 Review. No abstract available.

3

Long-term results of a double perfusion schedule using high dose hyperthermia and melphalan sequentially in extensive melanoma of the lower limb.

Noorda EM, Vrouenraets BC, Nieweg OE, Klaase JM, van der Zee J, Kroon BB. Noorda EM, et al. Among authors: kroon bb. Melanoma Res. 2003 Aug;13(4):395-9. doi: 10.1097/00008390-200308000-00009. Melanoma Res. 2003. PMID: 12883366 Clinical Trial.

4

Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.

Noorda EM, Vrouenraets BC, Nieweg OE, van Coevorden F, van Slooten GW, Kroon BB. Noorda EM, et al. Among authors: kroon bb. Cancer. 2003 Oct 1;98(7):1483-90. doi: 10.1002/cncr.11648. Cancer. 2003. PMID: 14508836 Free article.

5

Isolated limb perfusion prolongs the limb recurrence-free interval after several episodes of excisional surgery for locoregional recurrent melanoma.

Noorda EM, Takkenberg B, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, Hart GA, Kroon BB. Noorda EM, et al. Among authors: kroon bb. Ann Surg Oncol. 2004 May;11(5):491-9. doi: 10.1245/ASO.2004.04.032. Epub 2004 Apr 12. Ann Surg Oncol. 2004. PMID: 15078633

6

Isolated limb perfusion: what is the evidence for its use?

Noorda EM, Vrouenraets BC, Nieweg OE, Van Coevorden F, Kroon BB. Noorda EM, et al. Among authors: kroon bb. Ann Surg Oncol. 2004 Sep;11(9):837-45. doi: 10.1245/ASO.2004.12.042. Epub 2004 Aug 16. Ann Surg Oncol. 2004. PMID: 15313738

7

Isolated limb perfusion for unresectable melanoma of the extremities.

Noorda EM, Vrouenraets BC, Nieweg OE, van Geel BN, Eggermont AM, Kroon BB. Noorda EM, et al. Among authors: kroon bb. Arch Surg. 2004 Nov;139(11):1237-42. doi: 10.1001/archsurg.139.11.1237. Arch Surg. 2004. PMID: 15545572

8

Isolated limb perfusion in regional melanoma.

Noorda EM, Vrouenraets BC, Nieweg OE, Kroon BB. Noorda EM, et al. Among authors: kroon bb. Surg Oncol Clin N Am. 2006 Apr;15(2):373-84. doi: 10.1016/j.soc.2005.12.004. Surg Oncol Clin N Am. 2006. PMID: 16632221 Review.

9

Isolated limb perfusion for melanoma.

Kroon BB, Noorda EM, Vrouenraets BC, van Slooten GW, Nieweg OE. Kroon BB, et al. Surg Oncol Clin N Am. 2008 Oct;17(4):785-94, viii-ix. doi: 10.1016/j.soc.2008.04.005. Surg Oncol Clin N Am. 2008. PMID: 18722918 Review.

10

Isolated limb perfusion with melphalan for melanoma.

Nieweg OE, Kroon BB. Nieweg OE, et al. Among authors: kroon bb. J Surg Oncol. 2014 Mar;109(4):332-7. doi: 10.1002/jso.23558. Epub 2014 Jan 14. J Surg Oncol. 2014. PMID: 24421252 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page